Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer & Merck Mega Mergers Disappoint
Minyanville
Wednesday, February 2, 2011 - 3:10pm
tags:
M&A, Pfizer, Merck, Wyeth, Schering Plough
Lilly, Bristol-Myers halt drug study enrollment
Yahoo/AP
Wednesday, February 2, 2011 - 3:09pm
tags:
Eli Lilly, Bristol-Myers Squibb, cancer, necitumumab
Those Pharma Job Cuts Keep Coming, But…
Pharmalot
Wednesday, February 2, 2011 - 12:03pm
tags:
layoffs
FDA Catalyst Trade: Protalix BioTherapeutics
Seeking Alpha
Wednesday, February 2, 2011 - 12:02pm
tags:
FDA, Protalix BioTherapeutics, Pfizer, UPLYSO
Actavis Ordered To Pay $170M For Medicaid Fraud
Pharmalot
Wednesday, February 2, 2011 - 9:10am
tags:
Medicaid, fraud, Actavis
Four Pharma Stocks With Appealing Value, Dividend Yield
Seeking Alpha
Wednesday, February 2, 2011 - 9:08am
tags:
Eli Lilly, Merck, Pfizer, Bristol-Myers Squibb, dividends
Roche Reduces Avastin Forecast as Revenue Declines
Bloomberg
Wednesday, February 2, 2011 - 9:03am
tags:
Roche, Avastin, earnings
Seattle Genetics plans public stock offering
Yahoo/AP
Wednesday, February 2, 2011 - 9:01am
tags:
stock offering, Seattle Genetics
Heart Study Could Cost Twice Orexigen’s Market Cap
Forbes
Wednesday, February 2, 2011 - 8:44am
tags:
Orexigen, obesity, Contrave
Sanofi Diabetes Drug Worked as Well as Byetta in Study
Bloomberg
Wednesday, February 2, 2011 - 8:42am
tags:
Sanofi, diabetes, Byetta, lixisenatide, Amylin, Eli Lilly
GlaxoSmithKline sells stake in Quest for $1.7 bln
Marketwatch
Wednesday, February 2, 2011 - 8:40am
tags:
GSK, Quest
Earnings Preview: Merck to tout pipeline in report
Yahoo/AP
Wednesday, February 2, 2011 - 8:40am
tags:
Merck, earnings
Generic Risk Looms over Endo Pharma
Yahoo/Zacks.com
Tuesday, February 1, 2011 - 9:18pm
tags:
generics, Endo, Mylan, lidoderm
Analysts: Genzyme may fetch $77 a share
Bizjournals.com
Tuesday, February 1, 2011 - 9:15pm
tags:
Genzyme, Sanofi, M&A
Biogen 4Q profit drops 21 pct as expenses rise
Yahoo/AP
Tuesday, February 1, 2011 - 4:58pm
tags:
Biogen Idec, earnings
Why Qiagen's Earnings Are Outstanding
Motley Fool
Tuesday, February 1, 2011 - 4:57pm
tags:
earnings, Qiagen
Parexel Shares Plunged: What You Need to Know
Motley Fool
Tuesday, February 1, 2011 - 4:55pm
tags:
Parexel, Merck, Bristol-Myers Squibb
Sanofi Plans to Raise Genzyme Bid
NY Times, NY
Tuesday, February 1, 2011 - 4:53pm
tags:
M&A, Sanofi, Genzyme
Let It Snow, Let It Snow, I-P-O
InVivo
Tuesday, February 1, 2011 - 11:24am
tags:
Enycte, Pacira, AcelRx, IPOs
Obesity Drugs: The Road to Perdition
TheStreet.com
Tuesday, February 1, 2011 - 11:22am
tags:
obesity, Orexigen, Vivus, Arena Pharmaceuticals, Contrave, Qnexa, Lorqess

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.